Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.400
-0.280 (-5.98%)
At close: Dec 5, 2025, 4:00 PM EST
4.470
+0.070 (1.59%)
After-hours: Dec 5, 2025, 4:47 PM EST
Orchestra BioMed Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -75.1 | -61.02 | -49.12 | -33.61 | -23.01 | -21.36 |
| Depreciation & Amortization | 0.33 | 0.31 | 0.29 | 0.22 | 0.18 | 0.14 |
| Other Amortization | 0.18 | 0.03 | 0.11 | 0.16 | 0.22 | - |
| Asset Writedown & Restructuring Costs | 1.05 | 1.05 | - | - | - | - |
| Loss (Gain) From Sale of Investments | -0.72 | -1.43 | -3.8 | -1.63 | 0.29 | 2.93 |
| Stock-Based Compensation | 12.13 | 10.62 | 7.63 | 3.41 | 0.3 | 0.22 |
| Other Operating Activities | 1.36 | 0.67 | 2.08 | 2.6 | -0.03 | 0.07 |
| Change in Accounts Receivable | 0.08 | 0.02 | -0 | 0.03 | 0.05 | -0.08 |
| Change in Inventory | -0.13 | -0.03 | 0.13 | -0.21 | 0 | -0.03 |
| Change in Accounts Payable | 3.59 | 2.97 | 0.15 | 3.35 | 1.08 | -2.61 |
| Change in Unearned Revenue | -2.2 | -2.01 | -2.11 | -2.86 | 1.48 | -5.17 |
| Change in Other Net Operating Assets | -0.79 | -1.72 | -1.47 | -0.76 | 0.03 | -0.31 |
| Operating Cash Flow | -60.23 | -50.56 | -46.13 | -29.29 | -19.43 | -26.18 |
| Capital Expenditures | -0.56 | -0.29 | -0.08 | -0.59 | -0.27 | -0.54 |
| Cash Acquisitions | -0.6 | -0.6 | - | - | - | - |
| Investment in Securities | -11.82 | 13.98 | 10.77 | -63.53 | 13.5 | 27.69 |
| Other Investing Activities | - | - | - | - | -0.21 | -0.19 |
| Investing Cash Flow | -12.98 | 13.09 | 10.69 | -64.12 | 13.02 | 26.97 |
| Long-Term Debt Issued | - | 15 | - | 10 | - | 10 |
| Long-Term Debt Repaid | - | - | -10.85 | -6.45 | -4 | - |
| Net Debt Issued (Repaid) | 35 | 15 | -10.85 | 3.55 | -4 | 10 |
| Issuance of Common Stock | 57.92 | 15.28 | 0.25 | 0.2 | 0.01 | - |
| Repurchase of Common Stock | -1.63 | -0.55 | - | - | - | - |
| Other Financing Activities | -1.67 | -0.55 | 56.81 | -10.33 | - | - |
| Financing Cash Flow | 89.62 | 29.17 | 46.22 | 103.26 | -3.99 | 10 |
| Net Cash Flow | 16.41 | -8.3 | 10.78 | 9.85 | -10.41 | 10.78 |
| Free Cash Flow | -60.79 | -50.85 | -46.21 | -29.88 | -19.7 | -26.72 |
| Free Cash Flow Margin | -2157.31% | -1927.48% | -1674.09% | -845.74% | - | -468.56% |
| Free Cash Flow Per Share | -1.46 | -1.38 | -1.39 | -1.99 | -9.33 | -13.27 |
| Cash Interest Paid | 1.19 | 0.1 | 1.12 | 1.37 | 0.39 | - |
| Levered Free Cash Flow | -31.56 | -25.45 | -33.04 | -10.06 | -13.86 | - |
| Unlevered Free Cash Flow | -31.31 | -25.3 | -32.28 | -10.22 | -13.5 | - |
| Change in Working Capital | 0.55 | -0.77 | -3.31 | -0.45 | 2.63 | -8.19 |
Source: S&P Capital IQ. Standard template.
Financial Sources.